Hematology and Oncology Clinic at West Jefferson Mdical Center
Oncology
Dr. Robert M. Kessler, MD
|
|
Give Review
Doctor Robert M. Kessler, MD works in the field of Oncology. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Robert M. Kessler is a published doctor. He has 62 papers published. The most current publication "Comparison of three high affinity SPECT radiotracers for the dopamine D2 receptor." Robert Kessler accepts all Medicare patients.
Publications
- The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]f...
- Evidence for Chronically Altered Serotonin Function in the Cerebral Cortex of Female 3,4-Methylenedioxymethamphetamine Polydrug Users.
- Impact of isoflurane anesthesia on D2 receptor occupancy by [(18) F]fallypride measured by microPET with a modified Logan plot.
- Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects.
- Cerebral morphology and dopamine D2/D3 receptor distribution in humans: a combined [18F]fallypride and voxel-based morphometry study.
- Midbrain dopamine receptor availability is inversely associated with novelty-seeking traits in humans.
- Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats.
- Aripiprazole: what is the role of dopamine D(2) receptor partial agonism?
- Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine.
- Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol.
- Obesity: health insurance plans respond to a public health challenge.
- Weigh the risks before limiting coverage.
- Distribution of dopamine D2-like receptors in the human thalamus: autoradiographic and PET studies.
- Imaging methods for evaluating brain function in man.
- Regional selectivity in clozapine treatment?
- [18F]fluorodeoxyglucose positron emission tomography in refractory complex partial seizures.
- Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.
- Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.
- Isolated intrathoracic presentation of Mycobacterium avium complex in an immunocompetent child.
- Functional brain imaging.
- Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease.
- Positron emission tomography imaging-directed stereotactic neurosurgery.
- Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography.
- Estimation of left ventricular mass and infarct size from nitrogen-13-ammonia PET images based on pathological examination of explanted human hearts.
- Accurate localization of cortical convolutions in MR brain images.
- Cooperative T1 and T2 effects on contrast using a new driven inversion spin-echo (DISE) MRI pulse sequence.
- Noninvasive detection of acute rejection in a new experimental model of heart transplantation.
- Magnetic resonance brain tumor imaging in canine glioma.
- Gadolinium-enhanced MR angiography.
- Central nervous system lesions in pediatric patients: Gd-DTPA-enhanced MR imaging.
- Retrospective registration of PET and MR brain images: an algorithm and its stereotactic validation.
- Inhibitory motor seizures: correlation with centroparietal structural and functional abnormalities.
- Limbic encephalitis and hyperactive foci on PET scan.
- Postsurgical outcome of patients with uncontrolled complex partial seizures and temporal lobe hypometabolism on 18FDG-positron emission tomography.
- FDG-SPECT: correlation with FDG-PET.
- (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors.
- Craniopharyngioma: CT and MR imaging in nine cases.
- Noninvasive detection of heart transplant rejection with positron emission scintigraphy.
- Autoradiographic localization of dopamine D1 and D2 receptors in rat cerebral cortex following unilateral neurotoxic lesions.
- [125I]iodopride: a specific high affinity radioligand for labelling striatal dopamine D-2 receptors.
- Comparison and evaluation of retrospective intermodality brain image registration techniques.
- Retrospective intermodality registration techniques for images of the head: surface-based versus volume-based.
- Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
- Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
- Aromatic and amine substituent effects on the apparent lipophilicities of N-[(2-pyrrolidinyl)methyl]-substituted benzamides.
- Failure of the three compartment model to describe the pharmacokinetics in brain of a high affinity substituted benzamide.
- Comparison of three high affinity SPECT radiotracers for the dopamine D2 receptor.
- Dosimetry of iodine-123-epidepride: a dopamine D2 receptor ligand.
- High affinity dopamine D2 receptor radioligands. 3. [123I] and [125I]epidepride: in vivo studies in rhesus monkey brain and comparison with in vitro pharmacokinetics i...
- High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides.
- High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine...
- Estimation of baseline dopamine D2 receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [18F] fallypride.
- Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans.
- Visualization of extrastriatal dopamine D2 receptors in the human brain.
- Evaluation of 5-[18F]fluoropropylepidepride as a potential PET radioligand for imaging dopamine D2 receptors.
- Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride.
- Decreased dopamine type 2 receptor availability after bariatric surgery: preliminary findings.
- Time series fMRI measures detect changes in pontine raphé following acute tryptophan depletion.
- No increased herniation of the cerebellar tonsils in a group of patients with orthostatic intolerance.
- [(18)F]Fallypride dopamine D2 receptor studies using delayed microPET scans and a modified Logan plot.
- Sex differences in amphetamine-induced displacement of [(18)F]fallypride in striatal and extrastriatal regions: a PET study.
Procedures Preformed
- Plasmapheresis
Doctors Specialties
- Hematology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of South Florida -
Louisiana State University
Hospital
-
Ochsner Medical Center-Baton Rouge
Drug Facts
| NPI NUMBER | 1013972348 | |
| NPPES Provider LastName | KESSLER | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 700723120 | |
| NPPES Provider State | LA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 1349.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 129.0 | |
| Percent Opioid Claims | 9.56 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1013972348 |
| Last Name Of The Provider | KESSLER |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
Dr. Nagarajan Chandrasekaran, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Vijay M. Patel, MD |
|
Dr. Salvador Caputto, MD
This Doctor is OpenDoctor Recommended.
|